Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07485829 · ClinicalTrials.gov registry record

Zimmer Biomet-RibFix Titan

A clinical trial of Rib Fracture Multiple and Rib Fracture, sponsored by Zimmer Biomet.

Recruiting
Registry status
54
Enrollment target
1
Study location

NCT07485829 is a study of Rib Fracture Multiple and Rib Fracture that is actively recruiting participants, run by Zimmer Biomet. The registered enrollment target is 54 participants, below the 109-participant average among 4 other Rib Fracture Multiple trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07485829, a study of Rib Fracture Multiple and Rib Fracture, is actively recruiting participants, sponsored by Zimmer Biomet.

RECRUITING
Registry status
54 participants
Enrollment target
1
Study location

Study Summary

Prospective, single-center, non-randomized, single-cohort, post-market clinical follow-up study to confirm the safety, performance, and clinical benefits for the use of the RibFix Titan™ system implants and instrumentation) in the fusion, stabilization, and fixation of fractures in the chest wall including rib reconstructive surgical procedures, trauma, or planned osteotomies.

Interventions

  • DEVICE The RibFix Titan™ device should be used within this arm of the study.

Study Locations (1)

Indiana

  • Ascension St. Vincent Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 54 participants
Start Date 2026-03
Est. Completion 2028-03

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT07485829

The ClinicalTrials.gov registry entry for NCT07485829 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 4 other Rib Fracture Multiple trials with a reported enrollment target (50% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Rib Fracture Multiple appearing as the primary indexed condition, and to 1 intervention - of which The RibFix Titan™ device should be used within this arm of the study. is the first listed.

NCT07485829 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT07485829 about?

NCT07485829 is a clinical study titled "Zimmer Biomet-RibFix Titan". Prospective, single-center, non-randomized, single-cohort, post-market clinical follow-up study to confirm the safety, performance, and clinical benefits for the use of the RibFix Titan™ system implants and instrumentation) in the fusion, stabilization, and fixation of fractures in the chest wall in...

What is the current status of trial NCT07485829?

This trial is currently recruiting. The enrollment target is 54 participants. The study started on 2026-03. Estimated completion is 2028-03.

What conditions does trial NCT07485829 study?

This clinical trial studies the following conditions: Rib Fracture Multiple, Rib Fracture.

What interventions are being tested in trial NCT07485829?

The interventions under investigation include: The RibFix Titan™ device should be used within this arm of the study. (DEVICE).

Who is sponsoring clinical trial NCT07485829?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07485829 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rib Fracture Multiple

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.